Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ProStrakan, a Scotland-based developer of prescription medicines, has named Tom Stratford as the new CEO, effective 1 September 2011.
Subscribe to our email newsletter
Currently, he is serving as the executive VP of Business Development of the company and joined the subsidiary of Kyowa Hakko Kirin (KHK), ProStrakan in 1997.
Stratford said their ambition for the business is to build on ProStrakan’s successes in licensing, late stage development, registration and commercialisation of products and to continue to grow the business profitably.
"I look forward to helping ProStrakan to fulfil its promise as the springboard for KHK’s future success in Europe and the US as we bring KHK’s pipeline of products to market," Stratford said.